Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
How ADHD and Rejection Sensitive Dysphoria are linked
2+ week, 5+ day ago (36+ words) Yahoo Dr. Sasha Hamdani, a board-certified psychiatrist and ADHD clinical specialist, joins "CBS Mornings" to discuss the relationship between ADHD and Rejection Sensitive Dysphoria, also known as RSD....
Beyond Weight Loss: Glucagon-Like Peptide-1 Receptor Agonists and Antipsychotic Adherence in Schizophrenia
3+ week, 1+ day ago (23+ words) Cureus Download Cureus Media Kit Public user content licensed CC-BY 4.0...
Podcast: Misdiagnosis: What If You Suspect You Don’t Have Bipolar Disorder?
1+ mon, 3+ day ago (948+ words) Many people wonder whether their bipolar diagnosis is correct. Maybe your symptoms don’t match what you’ve learned. Maybe other circumstances — like trauma or substance use — better explain what you’ve experienced. Or maybe you’ve simply never felt confident that bipolar disorder…...
CKD BiO wins FDA nod, starts US trial of botulinum toxin for depression
1+ mon, 2+ week ago (15+ words) CHOSUNBIZ Chosunbiz...
Can ZEPHYR Schizophrenia Trial Data Light Up MapLight?
2+ mon, 2+ day ago (145+ words) RTTNews Can ZEPHYR Schizophrenia Trial Data Light Up MapLight? Schizophrenia is a serious mental disorder that affects thought processes, perception, emotions, and social interactions. In the United States, it affects about 3.2 million people (1.2% of adults), with approximately 1.5 new cases per…...
AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder
2+ mon, 1+ week ago (129+ words) Q1: Is this announcement an efficacy readout? A1: No. This announcement reports a clinical operations milestone. Efficacy and safety data will be reported with topline results in Q4 2026. Q2: What patient populations could VLS-01 target? Q3: Why is AtaiBeckley targeting MDD with VLS-01 rather than…...
Study finds positive attitude toward aging linked to cognitive, physical improvement
2+ mon, 1+ week ago (280+ words) QUINCY (WGEM) - A Yale study found that nearly half of more than 11,000 seniors improved cognitively and physically over time — and researchers linked those gains to a positive attitude toward aging. The study tracked adults 65 and older over 12 years. Researchers found…...
Weekly Rundown: Definium's psychedelic drug delivers rapid relief in major depression in late-stage study
2+ mon, 2+ week ago (1436+ words) Welcome to the Weekly Rundown where the DDN editors cover this week’s top biotech and pharma news. A new blood test can predict Alzheimer’s disease risk up to 25 years before symptoms appear. Imagine knowing your risk of dementia decades before…...
A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
2+ mon, 2+ week ago (207+ words) Jun 26, 2026, 09:30 ET Issued on behalf of Helus Pharma™ Helus Pharma™ (NASDAQ: HELP) (Cboe CA: HELP), the commercial operating name of Cybin Inc., says its APPROACH Phase 3 trial of HLP003 for adjunctive treatment of major depressive disorder has surpassed 86% enrollment, keeping the…...
Could Probiotics for Depression Be the Key to a Brighter Mood?
2+ mon, 3+ week ago (713+ words) If you’re interested in exploring probiotics for depression, here are some practical tips on how to include them in your diet: It’s important to recognize that not all probiotics are created equal. Different strains can have varying effects on mental…...